iShares Biotechnology ETF
BlackRock, Inc. IBB ETF
| IBB Price | $131.74 |
Market Cap | $5.37B |
| Annual Dividend Yield | 0.29% |
Annual Dividend | $0.38 |
| Yearly Management Fee | 0.44% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Biotechnology |
Last 24h Volume | $1.51M |
| Portfolio Management Company | BlackRock, Inc. |
Discount/Premium to NAV | -0.02% |
| Inception Date | Feb 05, 2001 |
Market Cap Rank | 312 |
| Monthly AUM Growth | -2.73% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Non-Leveraged |
| Description | Best investment Environment | Expected Return |
Invests in biotechnology sector stocks. This fund includes major companies in the biotechnology field. |
Innovation in biotechnology sector, favorable regulatory environment, and increased healthcare spending |
High return potential, high risk. |
iShares Biotechnology ETF is an ETF issued by BlackRock, Inc. on Feb 05 2001.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of IBB ETF according to its net asset value is discounted at -0.02%.
While the total value of the fund shows $-150,696,157 decrease compared to the previous month, its price is traded daily at a decrease of -0.23%.
The annual dividend yield of IBB ETF is 0.29%, whereas its main asset area is North America.
IBB ETF, whose 24-hour total volume is $1.51M, has experienced a $-86,843,891 cash outflow in the last month.
In addition, iShares Biotechnology ETF's 3-month net asset value total return is 13.33%.
IBB ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -0.23% |
-1.40% |
-0.78% |
8.62% |
-1.18% |
-0.90% |
-7.52% |
IBB ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 2.10% |
13.33% |
0.01% |
-4.22% |
-0.22% |
-2.17% |
IBB ETF Comments
no comments yet